About: LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.08 (-5.23%)
LENZ NASDAQ LENZ Therapeutics Inc
LENZ Therapeutics Inc share price
Atividade de preço de LENZ
Último preço
$ 3,160
Variação (24h)
-0,09 USD (2,77%)
Volume
695.97K
Volume (média 4 sem.)
-
Abertura
$ 3,23
Variação do dia
$ 3,06 - $ 3,23
Fechamento anterior
$ 3,25
Último negócio
23 Oct, 8:00 pm GMT+0
Atrasado
23 Oct, 8:00 pm GMT+0
LENZ price performance
Atrasado
23 Oct, 8:00 pm GMT+0
quote.marketSignals